Stay updated on Eli Lilly and Company Press Releases

Sign up to get notified when there's something new on the Eli Lilly and Company Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Eli Lilly and Company Press Releases page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Eli Lilly has launched Zepbound® (tirzepatide) single-dose vials, significantly reducing costs for obesity treatment, while also announcing participation in the upcoming Morgan Stanley Global Healthcare Conference.
    Difference
    100%
    Check dated 2024-08-28T02:04:06.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Eli Lilly announced significant advancements with tirzepatide, showing a 94% reduction in type 2 diabetes risk for adults with pre-diabetes and obesity, alongside a 22.9% average weight loss in a 176-week study, while also completing the acquisition of Morphic to enhance its immunology pipeline.
    Difference
    100%
    Check dated 2024-08-20T23:28:21.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Lilly has opened a new 346,000 square foot research and development center in the Boston Seaport, enhancing its genetic medicines efforts, while also reporting a significant 36% revenue increase in Q2 2024, raising its full-year revenue guidance by $3 billion.
    Difference
    100%
    Check dated 2024-08-13T22:22:39.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Lilly's tirzepatide has shown promising results in a phase 3 study for adults with heart failure and obesity, significantly reducing heart failure outcomes by 38% compared to placebo, while the company has also seen the departure of its CFO, Anat Ashkenazi.
    Difference
    14%
    Check dated 2024-08-06T21:26:08.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Eli Lilly has announced the date for its second-quarter 2024 financial results and a conference call on August 8, 2024, while the previous announcement regarding Melissa Seymour joining as executive vice president of Global Quality has been removed.
    Difference
    14%
    Check dated 2024-07-25T16:03:22.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Lilly has announced the acquisition of Morphic to enhance outcomes for patients with Inflammatory Bowel Disease by expanding their immunology pipeline with oral integrin therapies.
    Difference
    15%
    Check dated 2024-07-08T23:06:46.000Z thumbnail image

Stay in the know with updates to Eli Lilly and Company Press Releases

Enter your email address, and we'll notify you when there's something new on the Eli Lilly and Company Press Releases page.